Early research (Phase 1)Ended earlyNCT01663766
What this trial is testing
Phase I Study of Milatuzumab for Graft Versus Host Disease
Who this might be right for
GVHD (Acute or Chronic)Acute Myeloid or Lymphoblastic Leukemia (AML or ALL)Myelodysplastic Syndrome+4 more
Gilead Sciences 12